$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$76.97B
Market Cap
17.42
P/E Ratio
41.68
EPS
$790.98
52 Week High
$475.17
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Regeneron Pharmaceuticals, Inc. is a leading American biotechnology company based in Westchester County, New York, recognized for its innovative research in monoclonal antibodies and therapeutic proteins. The company has established a strong presence in key therapeutic areas, including oncology, ophthalmology, and immunology, with flagship products such as Eylea and Dupixent driving its success. Regeneron maintains a robust product pipeline, underscoring its dedication to scientific advancement and its influential role in addressing critical unmet medical needs within the biopharmaceutical industry.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK